CVR: 31762863
Secondary names: NOVVAC A/S, EVAXION BIOTECH A/S
Previous names: NOVVAC ApS, EVAXION BIOTECH ApS, EVAXION BIOTECH A/S
DKK 48,112,000
Revenue
Net result: DKK -51,489,000
BNY (Nominees) Limited (as nominee of The Bank of New York Mellon)
CVR · view ownership and management
Director registered: Helen Katrina Tayton-Martin
CVR · 24/11/2025
View the full event history
Evaxion A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named EVAXION BIOTECH A/S and EVAXION BIOTECH ApS. The management consists of Andreas Holm Mattsson, Thomas Frederik Schmidt and Helen Katrina Tayton-Martin. The company is owned by BNY (Nominees) Limited (as nominee of The Bank of New York Mellon). The company has 24 employees (2018). In 2025, the company reported revenue of DKK 48,112,000 and a net result of DKK -51,489,000 compared with DKK -73,277,000 the year before. Equity in the 2025 report amounted to DKK 108,250,000.
Source: annual report 2025, Danish Business Authority
Evaxion A/S has shown a significant recovery in revenue, achieving 48.1 million DKK in 2025, up from just 507,000 DKK in 2023. However, the company continues to face substantial losses, reporting a profit of -51.5 million DKK in 2025, although this is an improvement from -73.3 million DKK in 2024 and -152.4 million DKK in 2023. The equity position has stabilized at 108.3 million DKK, a notable recovery from a negative equity of -11.8 million DKK in 2024. Despite its growth in revenue, concerns remain regarding profitability and the sustainability of its financial trajectory within the competitive research and experimental development sector.
AI-generated summary · Generated 20/08/2026
Virksomhedens formål er at skabe avanceret software med henblik på udvikling af nye immunterapier og vacciner.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 48.1 mio. | -51.5 mio. | 180.5 mio. | 108.3 mio. | 45 | |
| 202401/01/2024 – 31/12/2024 | 22.3 mio. | -73.3 mio. | 94.7 mio. | -11.8 mio. | 46 | |
| 202301/01/2023 – 31/12/2023 | 507 t. | -152.4 mio. | 92.5 mio. | -31.9 mio. | 55 | |
| 202201/01/2022 – 31/12/2022 | - | -164.3 mio. | 150.4 mio. | 57.9 mio. | 59 | |
| 202101/01/2021 – 31/12/2021 | - | -154.9 mio. | 263 mio. | 212.8 mio. | 53 | |
| 202001/01/2020 – 31/12/2020 | - | -97.9 mio. | 70.5 mio. | 42.6 mio. | 33 | |
| 201901/01/2019 – 31/12/2019 | - | -10.8 mio. USD | 11.1 mio. USD | 9.3 mio. USD | - | |
| 201801/01/2018 – 31/12/2018 | - | -17.1 mio. | 54.1 mio. | 38.4 mio. | 18 | |
| 201701/01/2017 – 31/12/2017 | - | -10.4 mio. | 17.3 mio. | 15.8 mio. | 13 | |
| 201601/01/2016 – 31/12/2016 | - | -5 mio. | 11.6 mio. | 10 mio. | 14 | |
| 201501/01/2015 – 31/12/2015 | - | -6 mio. | 14.3 mio. | 13 mio. | - | |
| 201401/01/2014 – 31/12/2014 | - | -1.5 mio. | 10.5 mio. | 9.9 mio. | - | |
| 201301/01/2013 – 31/12/2013 | - | 419 t. | 978 t. | 539 t. | - | |
| 201201/01/2012 – 31/12/2012 | 1.4 mio. | 324 t. | 1.2 mio. | 119 t. | - |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvaxion A/S was founded on 11 August 2008.
Evaxion A/S is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
Evaxion A/S had 24 employees in 2018 according to the Danish CVR register.
Evaxion A/S is owned by BNY (Nominees) Limited (as nominee of The Bank of New York Mellon).
In 2025, Evaxion A/S reported revenue of DKK 48,112,000.
The management of Evaxion A/S consists of Andreas Holm Mattsson, Thomas Frederik Schmidt and Helen Katrina Tayton-Martin.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new email: [email protected] (August 24, 2026).
Contact info changed: new email: [email protected] (August 21, 2026).
Contact info changed: new email: [email protected] (August 20, 2026).
Evaxion A/S has published its annual report for 2025. Revenue came to DKK 48,112,000, and the net result was DKK -51,489,000.
Contact info changed: new email: [email protected] (April 16, 2026).
As of April 16, 2026, Jens Bitsch-Nørhave has joined the board of directors of Evaxion A/S.
Contact info changed: new email: [email protected] (February 24, 2026).
Contact info changed: new email: [email protected] (February 11, 2026).
As of November 24, 2025, Helen Katrina Tayton-Martin has left the board of directors of Evaxion A/S.
As of November 24, 2025, Helen Katrina Tayton-Martin is registered as adm. dir. of Evaxion A/S.
As of November 23, 2025, Birgitte Rønø has stepped down as adm. dir. of Evaxion A/S.
As of July 1, 2025, Birgitte Rønø is registered as adm. dir. of Evaxion A/S.
As of June 30, 2025, Christian Kanstrup has stepped down as adm. dir. of Evaxion A/S.
Evaxion A/S has published its annual report for 2024. Revenue came to DKK 22,324,000, and the net result was DKK -73,277,000.
As of April 30, 2025, Helen Katrina Tayton-Martin has joined the board of directors of Evaxion A/S.
On April 30, 2025, the company changed its name from EVAXION BIOTECH A/S to Evaxion A/S.
As of January 31, 2025, is registered as an owner of Evaxion A/S with an ownership share of 90%.
As of November 1, 2024, Thomas Frederik Schmidt is registered as director of Evaxion A/S.
As of October 31, 2024, Jesper Nyegaard Nissen has stepped down as director of Evaxion A/S.
As of June 30, 2024, Niels Iversen Møller has left the board of directors of Evaxion A/S.
Evaxion A/S has published its annual report for 2023. Revenue came to DKK 507,000, and the net result was DKK -152,414,000.
As of April 16, 2024, Lars Aage Staal Wegner has joined the board of directors of Evaxion A/S.
As of September 1, 2023, Christian Kanstrup is registered as adm. dir. of Evaxion A/S.
As of August 31, 2023, Per Göran Oskar Norlén has stepped down as adm. dir. of Evaxion A/S.
As of August 1, 2023, Jesper Nyegaard Nissen is registered as director of Evaxion A/S.
As of August 1, 2023, Bo Løkke Karmark has stepped down as director of Evaxion A/S.
Evaxion A/S has published its annual report for 2022. The net result was DKK -164,292,000.
As of May 24, 2023, Steven J. Projan has left the board of directors of Evaxion A/S.
As of October 1, 2022, Per Göran Oskar Norlén is registered as adm. dir. of Evaxion A/S.
As of October 1, 2022, Lars Aage Staal Wegner has stepped down as adm. dir. of Evaxion A/S.
Evaxion A/S has published its annual report for 2021. The net result was DKK -154,885,000.
As of May 23, 2022, Bo Løkke Karmark is registered as director of Evaxion A/S.
As of May 3, 2022, Niels Iversen Møller has joined the board of directors of Evaxion A/S.
As of April 1, 2022, Niels Iversen Møller has stepped down as director of Evaxion A/S.
Evaxion A/S has published its annual report for 2020. The net result was DKK -97,918,000.
As of May 25, 2021, Lars Holtug has joined the board of directors of Evaxion A/S.
As of May 25, 2021, Jo Ann Suzich has left the board of directors of Evaxion A/S.
As of May 25, 2021, Helen Marie Boudreau has left the board of directors of Evaxion A/S.
As of November 25, 2020, Marianne Søgaard has joined the board of directors of Evaxion A/S.
As of November 4, 2020, Kim Bjørnstrup has left the board of directors of Evaxion A/S.
Evaxion A/S has published its annual report for 2019. The net result was DKK -10,814,000.
As of June 30, 2020, Kim Bjørnstrup has joined the board of directors of Evaxion A/S.
As of June 30, 2020, Helen Marie Boudreau has joined the board of directors of Evaxion A/S.
As of June 30, 2020, Thomas William Wylonis has left the board of directors of Evaxion A/S.
As of June 25, 2020, EY Godkendt Revisionspartnerselskab has been appointed auditor of Evaxion A/S.
As of June 25, 2020, Christian Schwenn Albrecht Johansen has stepped down as auditor of Evaxion A/S.
As of May 15, 2020, Christian Schwenn Albrecht Johansen has been appointed auditor of Evaxion A/S.
As of May 15, 2020, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Evaxion A/S.
As of July 19, 2019, Jo Ann Suzich has joined the board of directors of Evaxion A/S.
Evaxion A/S has published its annual report for 2018. Gross profit came to DKK -8,390,221, and the net result was DKK -17,060,437.
On March 29, 2019, the company changed its name from EVAXION BIOTECH ApS to EVAXION BIOTECH A/S.
Evaxion A/S has published its annual report for 2017. Gross profit came to DKK -4,454,031, and the net result was DKK -10,370,605.
As of June 1, 2018, Steven J. Projan has joined the board of directors of Evaxion A/S.
As of June 1, 2018, Roberto Prego Pineda has joined the board of directors of Evaxion A/S.
As of June 1, 2018, Roberto Prego Novo has left the board of directors of Evaxion A/S.
As of July 1, 2017, Lars Aage Staal Wegner has left the board of directors of Evaxion A/S.
As of July 1, 2017, Lars Aage Staal Wegner is registered as adm. dir. of Evaxion A/S.
Evaxion A/S has published its annual report for 2016. Gross profit came to DKK -523,547, and the net result was DKK -5,022,641.
Evaxion A/S has published its annual report for 2015. Gross profit came to DKK -5,082,775, and the net result was DKK -6,029,250.
As of April 1, 2016, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Evaxion A/S.
As of April 1, 2016, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of Evaxion A/S.
Evaxion A/S has published its annual report for 2014. Gross profit came to DKK -399,331, and the net result was DKK -1,518,749.
As of December 16, 2014, Lars Aage Staal Wegner has joined the board of directors of Evaxion A/S.
As of December 16, 2014, Thomas William Wylonis has joined the board of directors of Evaxion A/S.
As of December 15, 2014, Lars Aage Staal Wegner has left the board of directors of Evaxion A/S.
As of December 15, 2014, Thomas William Wylonis has left the board of directors of Evaxion A/S.
As of September 18, 2014, Roberto Prego Novo has joined the board of directors of Evaxion A/S.
Evaxion A/S has published its annual report for 2013. Gross profit came to DKK 518,400, and the net result was DKK 419,463.
As of March 21, 2014, Lars Aage Staal Wegner has joined the board of directors of Evaxion A/S.
As of March 21, 2014, Thomas William Wylonis has joined the board of directors of Evaxion A/S.
On March 21, 2014, the company changed its name from NOVVAC ApS to EVAXION BIOTECH ApS.
Evaxion A/S has published its annual report for 2012. Revenue came to DKK 1,374,684, and the net result was DKK 324,467.
As of February 15, 2012, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Evaxion A/S.
As of February 15, 2012, DKNF 387 ApS has stepped down as auditor of Evaxion A/S.
As of June 15, 2011, DKNF 387 ApS has been appointed auditor of Evaxion A/S.
As of June 15, 2011, GBH REVISION & RÅDGIVNING REGISTRERET REVISIONSAKTIESELSKAB has stepped down as auditor of Evaxion A/S.
As of March 10, 2010, GBH REVISION & RÅDGIVNING REGISTRERET REVISIONSAKTIESELSKAB has been appointed auditor of Evaxion A/S.
As of March 10, 2010, PIVOT REVISION REGISTRERET REVISIONSSELSKAB A/S has stepped down as auditor of Evaxion A/S.
As of August 11, 2008, PIVOT REVISION REGISTRERET REVISIONSSELSKAB A/S has been appointed auditor of Evaxion A/S.
As of August 11, 2008, Andreas Holm Mattsson is registered as director of Evaxion A/S.
As of August 11, 2008, Niels Iversen Møller is registered as director of Evaxion A/S.
Evaxion A/S was founded on August 11, 2008.
Companies in the same industry and area
CVR 29312206
CVR 37053678
CVR 37726028
CVR 29217939
CVR 28512457
